Marion Blaize
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
Papers in
-
- Antifungal resistance and susceptibility 7
-
- Fungal Infections and Studies 6
- Nail Diseases and Treatments 2
- Co-authors
- Arnaud Fekkar (13 shared papers)Renaud Piarroux (9 shared papers)Alexandre Lampros (3 shared papers)Anne‐Geneviève Marcelin (2 shared papers)Julien Mayaux (2 shared papers)Anne‐Cécile Normand (6 shared papers)Sébastien Imbert (5 shared papers)Sophie Demeret (2 shared papers)
In The Last Decade
Marion Blaize
13 papers receiving 445 citations
Peers
Comparison fields: 5 of 62
- Applied Microbiology and Biotechnology 50
- Infectious Diseases 321
- Epidemiology 236
- Critical Care and Intensive Care Medicine 34
- Clinical Biochemistry 29
Countries citing papers authored by Marion Blaize
This map shows the geographic impact of Marion Blaize's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion Blaize with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion Blaize more than expected).
Fields of papers citing papers by Marion Blaize
This network shows the impact of papers produced by Marion Blaize. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion Blaize. The network helps show where Marion Blaize may publish in the future.
Co-authors
The 25 scholars most cited alongside Marion Blaize, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 112 | |
| 2 | 2020 | 98 | |
| 3 | 2021 | 54 | |
| 4 | 2019 | 48 | |
| 5 | 2021 | 33 | |
| 6 | 2022 | 33 | |
| 7 | 2021 | 23 | |
| 8 | 2023 | 18 | |
| 9 | 2022 | 14 | |
| 10 | 2024 | 6 | |
| 11 | 2024 | 5 | |
| 12 | 2023 | 5 | |
| 13 | 2021 | 1 | |
| 14 | 2024 | 0 |
About Marion Blaize
Marion Blaize is a scholar working on Infectious Diseases, Epidemiology, Cell Biology, Genetics and Clinical Biochemistry, having authored 14 papers that have together received 450 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (7 papers), Fungal Infections and Studies (6 papers), Plant Pathogens and Fungal Diseases (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Mycorrhizal Fungi and Plant Interactions (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), Nail Diseases and Treatments (2 papers) and Autoimmune Bullous Skin Diseases (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (50 citations), Infectious Diseases (321 citations), Epidemiology (236 citations), Critical Care and Intensive Care Medicine (34 citations) and Clinical Biochemistry (29 citations). Marion Blaize has collaborated with scholars based in France, Belgium and Denmark. Frequent co-authors include Arnaud Fekkar, Renaud Piarroux, Alexandre Lampros, Anne‐Geneviève Marcelin, Julien Mayaux, Anne‐Cécile Normand, Sébastien Imbert, Sophie Demeret, Antoine Monsel and Jean‐Michel Constantin. Their work appears in journals such as Journal of Fungi, Mycoses, Clinical Microbiology and Infection, International Journal of Infectious Diseases and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.